3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma, Follicular
9
Lymphoma
9
Leukemia, Lymphocytic, Chronic, B-Cell
8
Lymphoma, Mantle-Cell
7
Lymphoma, Non-Hodgkin
6
Lymphoma, Large B-Cell, Diffuse
4
Lymphoma, B-Cell
3
Waldenstrom Macroglobulinemia
2
Recurrence
2
Neoplasms
2
Lymphoma, B-Cell, Marginal Zone
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
1
Ovarian Neoplasms
1
Lymphoma, T-Cell, Peripheral
1
Lymphoma, T-Cell
1
Leukemia
1
Immunoblastic Lymphadenopathy
1
Hodgkin Disease
1
Hematologic Neoplasms
1
Hematologic Diseases
1
Fallopian Tube Neoplasms
1
Burkitt Lymphoma
1
Interventions
Etoposide
30
Carboplatin
29
atezolizumab
17
durvalumab
16
Cisplatin
14
Topotecan
11
Specimen Handling
9
PM 01183
9
Magnetic Resonance Spectroscopy
7
pembrolizumab
6
olaparib
5
berzosertib
4
anlotinib
4
Radiotherapy
4
Nivolumab
4
Irinotecan
4
Drug Therapy
4
tremelimumab
3
toripalimab
3
tislelizumab
3
Paclitaxel
3
Injections
3
Docetaxel
3
Biopsy
3
Bevacizumab
3
AMG 757
3
sacituzumab govitecan
2
monalizumab
2
cabozantinib
2
Temozolomide
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Small Cell Lung Carcinoma
×
Bendamustine Hydrochloride
×
90 days
×
Clear all
No trials found.